REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Paksi Galenus Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: PAKSI GALENUS Gyogyszerkereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Paksi Galenus Bt. is a company in Hungary, with a head office in Paks. The company operates in the Pharmacies and Drug Stores sector. It was first established on October 14, 1996. 6 (2024) employees currently work for Paksi Galenus Bt.. In 2023, the company reported a net sales revenue increase of 5.17%. Its’ total assets recorded a negative growth of 1.27%.

Headquarters
Dozsa Gy. u. 12. sz.
Paks; Tolna; Postal Code: 7030

Contact Details: Purchase the Paksi Galenus Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Paksi Galenus Bt. report to view the information.
Outstanding Shares:
Purchase the Paksi Galenus Bt. report to view the information.
Registered Capital:
Purchase the Paksi Galenus Bt. report to view the information.
Financial Auditors:
Purchase the Paksi Galenus Bt. report to view the information.
Incorporation Date:
October 14, 1996
Key Executives
Purchase this report to view the information.
Executive Officer
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Paksi Galenus Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
5.17%▲
Total operating revenue
4.57%▲
Operating profit (EBIT)
N/A
EBITDA
-74.59%▼
Net Profit (Loss) for the Period
N/A
Total assets
-1.27%▼
Total equity
-8.71%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.12%▼
Cash Ratio
-0.14%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo